J&J to acquire Ambrx Biopharma, a cancer drug developer, for $2B
An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson on …
An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson on …
Traders work on the floor of the New York Stock Exchange (NYSE) on the first day back since the Christmas holiday on December 26, 2023 in New York City. Spencer …
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in Washington, DC. Anna Moneymaker …
Legendary value investor Jeremy Grantham is betting on a special caliber of stocks with his firm’s first active ETF: the GMO U.S. Quality ETF. And he put GMO partner Tom …
Here are the most important news items that investors need to start their trading day: 1. Markets look for footing U.S. stock futures ticked higher Monday morning, as markets come …
Johnson & Johnson on Tuesday reported adjusted earnings and revenue that topped Wall Street’s expectations, and lifted its full-year guidance as sales in the company’s pharmaceutical and medical devices businesses …
CNBC’s Jim Cramer on Friday told investors what to look out for in the coming week as earnings season kicks off. He said news about the Israel-Hamas war is likely …
rewrite this content and keep HTML tags Kansas City Chiefs tight end Travis Kelce took a jab at Aaron Rodgers after the New York Jets quarterback called him “Mr. Pfizer,” …
McDonald’s french fries being prepared. Daniel Acker | Bloomberg | Getty Images Check out the companies making headlines in midday trading. Rivian Automotive — Rivian Automotive shares tanked 19% after …
US President Donald Trump (R) gestures as he talks with US Ambassador to the United Kingdom Woody Johnson (L) preparing to board Marine One to depart the US ambassador’s residence …